Sign up to save your podcasts
Or
Share E28-Brolucizumab for wet AMD (HAWK and HARRIER)- Dr. Pravin Dugel
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E28-Brolucizumab for wet AMD (HAWK and HARRIER)- Dr. Pravin Dugel
Dr. Dugel discusses 1 and 2 year results of HAWK and HARRIER on Brolucizumab for neovascular AMD.
Full reference:
Dugel, P. U., Koh, A., Ogura, Y., Jaffe, G. J., Schmidt-Erfurth, U., Brown, D. M., . . . Investigators, H. S. (2019). HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology. doi:10.1016/j.ophtha.2019.04.017
View all episodes
By Keyvan Koushan, MD, FRCSC
4.4
1111 ratings
Dr. Dugel discusses 1 and 2 year results of HAWK and HARRIER on Brolucizumab for neovascular AMD.
Full reference:
Dugel, P. U., Koh, A., Ogura, Y., Jaffe, G. J., Schmidt-Erfurth, U., Brown, D. M., . . . Investigators, H. S. (2019). HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology. doi:10.1016/j.ophtha.2019.04.017
More shows like The Retina Channel Podcast
View all
Ophthalmology off the Grid by Eyetube
43 Listeners
New Retina Radio by Eyetube
17 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
WashingtonWise
442 Listeners
Headlight in the fog: The Uveitis Podcast
20 Listeners
Pupil Pod
10 Listeners
Experts InSight
50 Listeners
RETINA Journal Podcasts
10 Listeners
Talking Euretina
1 Listeners
Ophthalmology Journal
18 Listeners
Mayo Clinic Ophthalmology Podcast
16 Listeners
ASRS's History of Retina
0 Listeners
Cataract Coach with Uday Devgan MD
16 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners
RetinaRounds™
0 Listeners